The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
National News India Approves Anhydrous Ammonia Fertilizer to Boost Sustainable Farming India has approved the…
The Reserve Bank of India (RBI) got permission from the Indian Government to roll out…
The e-Zero FIR system has been introduced by the Gujarat Government to facilitate cyber financial…
Gujarat has secured its position as a frontrunner among India’s states with Geographical Indication (GI)…
On 29th July, 2026 International Tiger Day will be observed worldwide, to raise the global…
In July 2026, Sarnath got included in the UNESCO World Heritage List which helped Uttar…